lidocaine and prilocaine

Asset

Blocks voltage-gated sodium channels to provide local anesthesia during periodontal treatment.

Stage
Approved
Modality
Small molecule
Target
Not known
2
Indications
12
Trials
1
Developer

Approved by the FDA on Dec 19, 2003 (NDA021451). FDA

Indications

2

In the full profile

  • Target and mechanism1
  • Owner and partners1
  • Trials12
  • Competitors12

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets